ACM

ADAR1 Capital Management Portfolio holdings

AUM $1.34B
1-Year Est. Return 288.83%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+288.83%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.01B
AUM Growth
+$394M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
251
New
Increased
Reduced
Closed

Top Buys

1
+$27.6M
2
+$20.5M
3
+$17.4M
4
ETNB
89bio
ETNB
+$12.6M
5
JANX icon
Janux Therapeutics
JANX
+$7.04M

Top Sells

1
+$105M
2
+$14.6M
3
+$7.97M
4
SAGE
Sage Therapeutics
SAGE
+$6.58M
5
VERV
Verve Therapeutics
VERV
+$5.27M

Sector Composition

1 Healthcare 87.7%
2 Financials 1.74%
3 Communication Services 0.1%
4 Consumer Discretionary 0.1%
5 Technology 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANSC
151
Agriculture & Natural Solutions Acquisition Corp
ANSC
$465M
$296K 0.03%
27,062
AKRO
152
DELISTED
Akero Therapeutics
AKRO
$292K 0.03%
6,143
-27,000
NRIX icon
153
Nurix Therapeutics
NRIX
$1.63B
$288K 0.03%
31,200
PCAPU
154
ProCap Acquisition Corp Unit
PCAPU
$210M
$283K 0.03%
26,940
+16,260
HRMY icon
155
Harmony Biosciences
HRMY
$1.66B
$282K 0.03%
+10,245
RARE icon
156
Ultragenyx Pharmaceutical
RARE
$2.22B
$271K 0.03%
+9,000
CLYM
157
Climb Bio
CLYM
$482M
$268K 0.03%
133,530
+14,210
BMRN icon
158
BioMarin Pharmaceuticals
BMRN
$11.5B
$265K 0.03%
4,900
VTYX icon
159
Ventyx Biosciences
VTYX
$1B
$254K 0.03%
81,600
-87,000
ALMS
160
Alumis Inc
ALMS
$3.71B
$245K 0.02%
61,291
+23,503
SAVA icon
161
Cassava Sciences
SAVA
$112M
$236K 0.02%
+81,000
TXMD icon
162
TherapeuticsMD
TXMD
$25.9M
$225K 0.02%
209,210
KALA icon
163
KALA BIO
KALA
$354M
$217K 0.02%
141,995
-7,835
SPRO icon
164
Spero Therapeutics
SPRO
$123M
$217K 0.02%
115,539
-28,378
BCAX
165
Bicara Therapeutics
BCAX
$964M
$216K 0.02%
13,705
-9,170
IFRX icon
166
InflaRx
IFRX
$62.3M
$214K 0.02%
+159,479
DAWN icon
167
Day One Biopharmaceuticals
DAWN
$1.06B
$198K 0.02%
28,023
HELP
168
Cybin Inc
HELP
$380M
$196K 0.02%
+33,278
CMPX icon
169
Compass Therapeutics
CMPX
$1.01B
$175K 0.02%
50,000
+25,000
RXRX icon
170
Recursion Pharmaceuticals
RXRX
$1.89B
$171K 0.02%
35,000
PEPG icon
171
PepGen
PEPG
$449M
$170K 0.02%
36,842
+16,490
KPTI icon
172
Karyopharm Therapeutics
KPTI
$176M
$164K 0.02%
+25,000
VYGR icon
173
Voyager Therapeutics
VYGR
$231M
$163K 0.02%
35,000
-44,945
TARA icon
174
Protara Therapeutics
TARA
$320M
$153K 0.02%
35,223
-87,467
ACHV icon
175
Achieve Life Sciences
ACHV
$246M
$151K 0.01%
47,800
+4,627
5 6
7
8 9